8-K
filed February 7, 2023, 6:59 PM ET
ticker CNC
CIK 0001071739
earnings
confidence high
sentiment neutral
materiality 0.75
Centene Q4 adj EPS $0.86, full-year adj EPS $5.78; revenue $144.5B (+15% YoY); guidance raised
CENTENE CORP
2022-FY EPS reported
$2.07
revenue$144,547,000,000
- Q4 total revenues $35.6B (+9% YoY); full-year 2022 revenues $144.5B (+15% YoY).
- Q4 GAAP diluted EPS $(0.38) includes $528M in impairments; adjusted diluted EPS $0.86.
- Full-year 2022 adjusted diluted EPS $5.78 (+12% YoY); health benefits ratio 87.7%.
- Completed five divestitures (Magellan Rx, Magellan Specialty Health, Ribera Salud, Centurion, HealthSmart).
- 2023 premium/service revenue guidance raised $2B to $131.5B-$133.5B; adj EPS guidance unchanged $6.25-$6.40.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
CENTENE CORP reported year ended December 31, 2022 results: revenue $144,547, EPS $2.07. Guidance raised.
- Period
- year ended December 31, 2022
- Revenue
- $144,547
- EPS
- $2.07
- Guidance
- raised
- Result
- reported results
Exact text from the filing
In summary, the 2022 fourth quarter and full year results were as follows: 2022 Results Q4 Full Year Total revenues (in millions) $ 35,561 $ 144,547 Premium and service revenues (in millions) $ 33,553 $ 135,479 Health benefits ratio 88.7 % 87.7 % SG&A expense ratio 9.5 % 8.6 % Adjusted SG&A expense ratio (1) 9.3 % 8.4 % GAAP diluted earnings (loss) per share $ (0.38) $ 2.07 Adjusted diluted EPS (1) $ 0.86 $ 5.78
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
CENTENE CORP reported fourth quarter ended December 31, 2022 results: revenue $35,561, EPS $ (0.38). Guidance raised.
- Period
- fourth quarter ended December 31, 2022
- Revenue
- $35,561
- EPS
- $ (0.38)
- Guidance
- raised
- Result
- reported results
Exact text from the filing
In summary, the 2022 fourth quarter and full year results were as follows: 2022 Results Q4 Full Year Total revenues (in millions) $ 35,561 $ 144,547 Premium and service revenues (in millions) $ 33,553 $ 135,479 Health benefits ratio 88.7 % 87.7 % SG&A expense ratio 9.5 % 8.6 % Adjusted SG&A expense ratio (1) 9.3 % 8.4 % GAAP diluted earnings (loss) per share $ (0.38) $ 2.07 Adjusted diluted EPS (1) $ 0.86 $ 5.78
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.